AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of Buy from Analysts

AtriCure, Inc. (NASDAQ:ATRC – Get Rating) has been assigned an average recommendation of “Buy” from the five brokerages that are currently covering the stock, MarketBeat Ratings reports. Five investment analysts have rated the stock with a buy recommendation. The average 12-month target price among brokerages that have issued a report on the stock in the […]

Related Keywords

United States ,Stifel Nicolaus ,Karen Prange ,Maggie Yuen ,Metlife Investment Management ,Alphacrest Capital Management ,Atricure Company Profile ,Sei Investments Co ,Nasdaq ,Atricure Inc ,Dimensional Fund Advisors ,Financial Services Group Inc ,Needham Company ,Canaccord Genuity Group ,Get Rating ,Marketbeat Ratings ,Genuity Group ,Cure Stock Down ,Director Karen Prange ,Director Maggie Yuen ,Services Group ,Crest Capital Management ,Life Investment Management ,Fund Advisors ,Sei Investments ,Isolator Synergy Clamps ,Atricure Daily ,Atricure ,Nasdaq Atrc ,Atrc ,Medical ,04963c20 ,Ratings ,Consensus ,